DOI QR코드

DOI QR Code

How we should approach and manage older patients with cancer

노인 암 환자의 접근과 관리 원칙

  • Kim, Jee Hyun (Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital)
  • 김지현 (서울대학교 의과대학, 분당서울대학교병원 혈액종양내과)
  • Received : 2017.10.15
  • Accepted : 2017.11.03
  • Published : 2017.11.30

Abstract

Cancer is the disease of aging and Korea is one of the fastest aging country in the world. Older patients have decreased organ function and stress tolerance, therefore are at high risk of functional decline and developing complication from cancer and cancer treatment. Before beginning cancer treatment, it is important to assess patients' life expectancy, whether the patient is likely to die of cancer or of other comorbidity, and also the risks with cancer treatment. In order to estimate patient's physiologic age, it is recommended to perform geriatric assessment and implement appropriate geriatric intervention together with meticulous supportive care, when planning cancer treatment for older patients. In a resource limited country such as Korea, two step approach of applying screening tool followed by geriatric assessment can be more efficient. Geriatric assessment is used to predict toxicity from cancer treatment such as surgery, radiotherapy, and chemotherapy, predict survival, and also to aid treatment decision. Number of randomized trials are ongoing to compare usual care versus oncogeriatric care, and with these results we expect to improve outcome of older patients with cancer.

Keywords

References

  1. Howlader N NA, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) SEER Cancer Statistics Review, 1975-2014, National Cancer Institute 2017.
  2. 대한민국통계청. 2015년 사망원인 통계연보. 2016.
  3. 중앙암등록본부. 국가암등록사업 연례보고서 (2014년 암등록통계). 2016.
  4. Sawhney R, Sehl M, Naeim A. Physiologic aspects of aging: impact on cancer management and decision making, part I. Cancer J. 2005;11:449-460. https://doi.org/10.1097/00130404-200511000-00004
  5. Sehl M, Sawhney R, Naeim A. Physiologic aspects of aging: impact on cancer management and decision making, part II. Cancer J. 2005;11:461-473. https://doi.org/10.1097/00130404-200511000-00005
  6. Korc-Grodzicki B, Boparai MK, Lichtman SM. Prescribing for older patients with cancer. Clin Adv Hematol Oncol. 2014;12:309-318.
  7. 대한민국통계청. 2015년 생명표. 2016.
  8. Arias E. Life Tables of the United States, 2008. 2012;61:1-64.
  9. Jung HW, Kim JW, Han JW, Kim K, Kim JH, Kim KI, et al. Multidimensional Geriatric Prognostic Index, Based on a Geriatric Assessment, for Long-Term Survival in Older Adults in Korea. PLoS One. 2016;11:e0147032. https://doi.org/10.1371/journal.pone.0147032
  10. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: A systematic review. JAMA. 2012;307:182-192. https://doi.org/10.1001/jama.2011.1966
  11. Li D, de Glas NA, Hurria A. Cancer and Aging: General Principles, Biology, and Geriatric Assessment. Clin Geriatr Med. 2016;32:1-15. https://doi.org/10.1016/j.cger.2015.08.003
  12. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255-263. https://doi.org/10.1093/gerona/59.3.M255
  13. Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014;32:2595-2603. https://doi.org/10.1200/JCO.2013.54.8347
  14. Cohen HJ, Feussner JR, Weinberger M, Carnes M, Hamdy RC, Hsieh F, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med. 2002;346:905-912. https://doi.org/10.1056/NEJMsa010285
  15. Korc-Grodzicki B, Holmes HM, Shahrokni A. Geriatric assessment for oncologists. Cancer Biol Med. 2015;12:261-274.
  16. Mor V, Wilcox V, Rakowski W, Hiris J. Functional transitions among the elderly: patterns, predictors, and related hospital use. Am J Public Health. 1994;84:1274-1280. https://doi.org/10.2105/AJPH.84.8.1274
  17. Gourin CG, Couch ME, Johnson JT. Effect of weight loss on short-term outcomes and costs of care after head and neck cancer surgery. Ann Otol Rhinol Laryngol. 2014;123:101-110. https://doi.org/10.1177/0003489414523564
  18. Langius JA, Bakker S, Rietveld DH, Kruizenga HM, Langendijk JA, Weijs PJ, et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer. 2013;109:1093-1099. https://doi.org/10.1038/bjc.2013.458
  19. Vellas B, Guigoz Y, Garry PJ, Nourhashemi F, Bennahum D, Lauque S, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15:116-122. https://doi.org/10.1016/S0899-9007(98)00171-3
  20. Wolfson C, Wolfson DB, Asgharian M, M'Lan CE, Ostbye T, Rockwood K, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med. 2001;344:1111-1116. https://doi.org/10.1056/NEJM200104123441501
  21. Podsiadlo D, Richardson S. The timed "Up &Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142-148. https://doi.org/10.1111/j.1532-5415.1991.tb01616.x
  22. Kilgour RD, Vigano A, Trutschnigg B, Lucar E, Borod M, Morais JA. Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer. 2013;21:3261-3270. https://doi.org/10.1007/s00520-013-1894-4
  23. Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33:1453-1459. https://doi.org/10.1200/JCO.2014.58.7550
  24. Caillet P, Laurent M, Bastuji-Garin S, Liuu E, Culine S, Lagrange JL, et al. Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment. Clin Interv Aging. 2014;9:1645-1660.
  25. Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20:494-502. https://doi.org/10.1200/JCO.2002.20.2.494
  26. Pope D, Ramesh H, Gennari R, Corsini G, Maffezzini M, Hoekstra HJ, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15:189-197. https://doi.org/10.1016/j.suronc.2007.04.009
  27. Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol. 2011;29:3620-3627. https://doi.org/10.1200/JCO.2010.32.0796
  28. Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol. 2012;30:1829-1834. https://doi.org/10.1200/JCO.2011.35.7442
  29. Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29:3457-3465. https://doi.org/10.1200/JCO.2011.34.7625
  30. Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118:3377-3386. https://doi.org/10.1002/cncr.26646
  31. Kim SW, Han HS, Jung HW, Kim KI, Hwang DW, Kang SB, et al. Multidimensional frailty score for the prediction of postoperative mortality risk. JAMA Surg. 2014;149:633-640. https://doi.org/10.1001/jamasurg.2014.241
  32. VanderWalde NA, Deal AM, Comitz E, Stravers L, Muss H, Reeve BB, et al. Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017;98:850-857. https://doi.org/10.1016/j.ijrobp.2016.11.048
  33. Caillet P, Canoui-Poitrine F, Vouriot J, Berle M, Reinald N, Krypciak S, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol. 2011;29:3636-3642. https://doi.org/10.1200/JCO.2010.31.0664
  34. Kenis C, Bron D, Libert Y, Decoster L, Van Puyvelde K, Scalliet P, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol. 2013;24:1306-1312. https://doi.org/10.1093/annonc/mds619
  35. Saliba D, Elliott M, Rubenstein LZ, Solomon DH, Young RT, Kamberg CJ, et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49:1691-1699. https://doi.org/10.1046/j.1532-5415.2001.49281.x
  36. Soubeyran P, Bellera C, Goyard J, Heitz D, Cure H, Rousselot H, et al. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study. PLoS One. 2014;9:e115060. https://doi.org/10.1371/journal.pone.0115060
  37. Overcash JA, Beckstead J, Moody L, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol. 2006;59:205-210. https://doi.org/10.1016/j.critrevonc.2006.04.003
  38. 조비룡 손, 오범조, 김석중, 권인순, 박병주, 선우덕, 윤종률, 원장원, 황환식, 가혁. 한국형 외래 노인건강평가도구의 개발 및 타당도, 신뢰도 조사. J Korean Geriatr Soc 2013;17:18-27. https://doi.org/10.4235/jkgs.2013.17.1.18
  39. Kim JW, Kim SH, Kim YJ, Lee KW, Kim KI, Lee JS, et al. A Novel Geriatric Screening Tool in Older Patients with Cancer: The Korean Cancer Study Group Geriatric Score (KG)-7. PLoS One. 2015;10:e0138304. https://doi.org/10.1371/journal.pone.0138304
  40. Brugel L, Laurent M, Caillet P, Radenne A, Durand-Zaleski I, Martin M, et al. Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR). BMC Cancer. 2014;14:427. https://doi.org/10.1186/1471-2407-14-427
  41. Soubeyran P, Terret C, Bellera C, Bonnetain F, Jean OS, Galvin A, et al. Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial. BMC Cancer. 2016;16:932. https://doi.org/10.1186/s12885-016-2927-4
  42. Kalsi T, Babic-Illman G, Ross PJ, Maisey NR, Hughes S, Fields P, et al. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. Br J Cancer. 2015;112:1435-1444. https://doi.org/10.1038/bjc.2015.120